HIK/N fundamentals
HIKMA PHARMACEUTICALS financial statements, including revenue, expenses, and profit
The total revenue of HIK/N for the last semiannual is 31.48 B MXN, and it's 9.44% higher compared to the previous semiannual. The net income of H2 24 is 2.69 B MXN.
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: MXN
TTM